The Prevalence of Postoperative Nausea and Vomiting in Orthopedic Patients in Imam Khomeini Hospital Complex during 2018-2019: A Cross-Sectional Study

Amirhossein Orandi; Hamidreza Amiri; Kianoush Saberi; Mojgan Rahimi; Maryam Chakeri Yazdi

doi:10.18502/aacc.v9i5.13965

The Prevalence of Postoperative Nausea and Vomiting in Orthopedic Patients in Imam Khomeini Hospital Complex during 2018-2019: A Cross-Sectional Study

Abstract

Background: Postoperative nausea and vomiting (PONV) is one of the most common postoperative complaints of the patients that affects the surgical outcome, quality of life, length of hospital stay, and costs. The prevalence of nausea and vomiting is estimated at 52% and 25% within the first 24 hours after surgery. Many risk factors have been identified for PONV, including female gender, being a non-smoker, young age, general anesthesia, use of volatile anesthetics and Nitrous Oxide, and duration of anesthesia. Following receiving reports indicating an unusually high prevalence of PONV in the male orthopedic ward of Imam Khomeini Hospital Complex despite applying regional techniques, the present study was conducted to investigate its prevalence and possible reasons.
Methods: After obtaining informed consent, 300 patients admitted to male and female orthopedic wards of Imam Khomeini Hospital complex that had undergone surgery within the past 48 hours were interviewed in person and their medical records were reviewed.
Results: Of 300 patients, 61 (20.3%) had nausea and 39 (13%) had vomiting. Three patients (1%) experienced recurrence of PONV after treatment. The risk factors associated with PONV were female gender, history of motion sickness, general anesthesia with sodium thiopental, atracurium, IV lidocaine, isoflurane, neostigmine, and postoperative administration of ciprofloxacin.
Conclusion: The prevalence of PONV was lower than other studies, which was in contrast to reports received from the ward, indicating a reduction in PONV following the use of regional techniques.

[1] Okamura K, Sanuki M, Kinoshita H, Fujii K, Matsunaga A. [Study of nausea and vomiting accompanying intravenous patient-controlled analgesia with fentanyl after cervical spine surgery]. Masui. 2003; 52(11):1181-5.
[2] Muchatuta NA, Paech MJ. Management of postoperative nausea and vomiting: focus on palonosetron. Ther Clin Risk Manag. 2009; 5(1):21-34.
[3] Swaro S, Karan D, Banerjee A. Comparison of Palonosetron, Dexamethasone, and Palonosetron Plus Dexamethasone as Prophylactic Antiemetic and Antipruritic Drug in Patients Receiving Intrathecal Morphine for Lower Segment Cesarean Section. Anesth Essays Res. 2018; 12(2):322-7.
[4] Shetti AN, Singh DR, Nag K, Shetti RA, Kumar VRH. Improved prophylaxis of postoperative nausea vomiting: Palonosetron a novel antiemetic. Anesth Essays Res. 2014; 8(1):9-12.
[5] Swaika S, Pal A, Chatterjee S, Saha D, Dawar N. Ondansetron, ramosetron, or palonosetron: Which is a better choice of antiemetic to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy? Anesth Essays Res. 2011; 5(2):182-6.
[6] Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 1999; 91(3):693-700.
[7] Hill RP, Lubarsky DA, Phillips-Bute B, Fortney JT, Creed MR, Glass PS, et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology. 2000; 92(4):958-67.
[8] Alexander R, Lovell AT, Seingry D, Jones RM. Comparison of ondansetron and droperidol in reducing postoperative nausea and vomiting associated with patient-controlled analgesia. Anaesthesia. 1995; 50(12):1086-8.
[9] Wesmiller SW, Henker RA, Sereika SM, Donovan HS, Meng L, Gruen GS, et al. The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients. Biol Res Nurs. 2013; 15(4):382-9.
[10] Schwarzkopf R, Snir N, Sharfman ZT, Rinehart JB, Calderon MD, Bahn E, et al. Effects of Modification of Pain Protocol on Incidence of Post Operative Nausea and Vomiting. Open Orthop J. 2016; 10:505-11.
[11] Kim BG, Kim H, Lim HK, Yang C, Oh S, Lee BW. A comparison of palonosetron and dexamethasone for postoperative nausea and vomiting in orthopedic patients receiving patient-controlled epidural analgesia. Korean J Anesthesiol. 2017; 70(5):520-6.
[12] Sinclair David R, Chung F, Mezei G. Can Postoperative Nausea and Vomiting Be Predicted? Anesthesiology. 1999; 91(1):109-18.
[13] Kranke P, Apefel CC, Papenfuss T, Rauch S, Löbmann U, Rübsam B, et al. An increased body mass index is no risk factor for postoperative nausea and vomiting. A systematic review and results of original data. Acta Anaesthesiol Scand. 2001; 45(2):160-6.
[14] Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014; 118(1):85-113.
[15] Gralla R, Lichinitser M, Van Der Vegt S, Sleeboom H, Mezger J, Peschel C, et al. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol. 2003; 14(10):1570-7.
[16] Ryoo SH, Yoo JH, Kim MG, Lee KH, Kim SI. The effect of combination treatment using palonosetron and dexamethasone for the prevention of postoperative nausea and vomiting versus dexamethasone alone in women receiving intravenous patient-controlled analgesia. Korean J Anesthesiol. 2015; 68(3):267-73.
[17] Wang J-J, Tzeng J-I, Ho S-T, Chen J-Y, Chu C-C, So EC. The prophylactic effect of tropisetron on epidural morphine-related nausea and vomiting: a comparison of dexamethasone with saline. Anesth Analg. 2002; 94(3):749-53.
[18] Szarvas S, Chellapuri RS, Harmon DC, Owens J, Murphy D, Shorten GD. A comparison of dexamethasone, ondansetron, and dexamethasone plus ondansetron as prophylactic antiemetic and antipruritic therapy in patients receiving intrathecal morphine for major orthopedic surgery. Anesth Analg. 2003; 97(1):259-63.
[19] Pirat A, Tuncay SF, Torgay A, Candan S, Arslan G. Ondansetron, orally disintegrating tablets versus intravenous injection for prevention of intrathecal morphine-induced nausea, vomiting, and pruritus in young males. Anesth Analg. 2005; 101(5):1330-6.
[20] Pitkänen MT, Niemi L, Tuominen MK, Rosenberg PH. Effect of tropisetron, a 5-HT3 receptor antagonist, on analgesia and nausea after intrathecal morphine. Br J Anaesth. 1993; 71(5):681-4.
[21] Pitkänen MT, Numminen MK, Tuominen MK, Rosenberg PH. Comparison of metoclopramide and ondansetron for the prevention of nausea and vomiting after intrathecal morphine. Eur J Anaesthesiol. 1997; 14(2):172-7.

Files	XML pdf (542KB)
Issue	Vol 9 No Supp. 1 (2023): Supplement 1
Section	Research Article(s)
DOI	https://doi.org/10.18502/aacc.v9i5.13965
Keywords
Nausea Vomiting Postoperative period PONV Orthopedic surgery Complications

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

Orandi A, Amiri H, Saberi K, Rahimi M, Chakeri Yazdi M. The Prevalence of Postoperative Nausea and Vomiting in Orthopedic Patients in Imam Khomeini Hospital Complex during 2018-2019: A Cross-Sectional Study. Arch Anesth & Crit Care. 2023;9(Supp. 1):444-449.

Vancouver

Download Citation